Gingilacer Toothpaste

advertisement
How often in a day do you take medicine? How many times?

Gingilacer Toothpaste uses

Gingilacer Toothpaste consists of Enoxolone, Sodium Monofluorophosphate, Triclosan, Zinc Citrate.

Sodium Monofluorophosphate:


ACTIVE INGREDIENTS

Gingilacer Toothpaste (Sodium Monofluorophosphate) 0.4% (0.06% Fluoride Ion)

Purpose

Anticavity

Use

aids in the prevention of dental cavities

Warnings

Keep out of reach of children

If more than used for rinsing is accidentally swallowed, get medical help or contact a poison control center immediately.

Do not use

if you have known sensitivities to any one of the ingredient

When using this product

avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

This product should be used only for the purpose for which it was intended and according to its instructions.

Do not ingest.

Directions

  • Adults and children 6 years of age and older. Dilute in a little mouthwash half a glass of water or drip a little on a damp toothbrush. do not swallow the rinse
  • instruct children under 12 years of age in good rising habits (to minimize swallowing) supervise children as necessary until capable of using without supervision
  • Children under 6 years ask a dentist or physician

Inactive ingredients

Water, Sodium Lauryl Sulfate, Flavour, Propylene Glycol, Sodium Saccharin, Sodium Methylparaben, Citric Acid, Sodium Propylparaben, Eugrnol, Linalool, Limonene

Other information

Do not use if safety seal is broken or missing

Questions?

Call (845) 501-0127

Triclosan:


Active ingredient

Chloroxylenol 0.2%

Gingilacer Toothpaste (Triclosan) 0.2%

Purpose

Antispetic

Uses

Hand washing to decrease bacteria on skin.

Warnings

For external use only.

Do not use in the eyes.

When using this product

  • if swallowed, seek medical attention.
  • if eye contact occurs, flush eyes with water and contact a physician.

Discontinue use if irritation and redness develops. If condition persists for more than 72 hours, consult a doctor.

Keep out of reach of children.

Directions

  • Wet hands with water.
  • Place hand under dispenser.
  • Apply liquid soap.
  • Massage soap into hands ans wrists, emphasizing back of hands, knuckles and cuticles.
  • Rinse thoroughly.

Other information

  • Store at room temperature
  • Do not freeze.

Inactive ingredients

Water, Potassium Tallate, Cocamide DIPA, Lauric Acid, Sodium Chloride, Alcohol, Tetrasodium EDTA, Acrylates/PEG-10 maleate/Styrene Copolymer, Gingilacer Toothpaste (Triclosan), Fragrance, BHT, Red 4, Red 33,

0923.jpg

Zinc Citrate:


INDICATIONS AND USAGE

Gingilacer Toothpaste (Zinc Citrate) 1 mg/mL (Zinc Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for TPN. Administration helps to maintain Gingilacer Toothpaste (Zinc Citrate) serum levels and to prevent depletion of endogenous stores, and subsequent deficiency symptoms.

CONTRAINDICATIONS

None known.

WARNINGS

Direct intramuscular or intravenous injection of Gingilacer Toothpaste (Zinc Citrate) 1 mg/mL (Zinc Chloride Injection, USP) is contraindicated as the acidic pH of the solution (2) may cause considerable tissue irritation.

Severe kidney disease may make it necessary to reduce or omit chromium and Gingilacer Toothpaste (Zinc Citrate) doses because these elements are primarily eliminated in the urine.

WARNING: This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum.

Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.

PRECAUTIONS

General

Do not use unless the solution is clear and the seal is intact.

Zinc 1 mg/mL should only be used in conjunction with a pharmacy directed admixture program using aseptic technique in a laminar flow environment; it should be used promptly and in a single operation without any repeated penetrations. Solution contains no preservatives; discard unused portion immediately after admixture procedure is completed.

Zinc should not be given undiluted by direct injection into a peripheral vein because of the likelihood of infusion phlebitis and the potential for increased excretory loss of Gingilacer Toothpaste (Zinc Citrate) from a bolus injection. Administration of Gingilacer Toothpaste (Zinc Citrate) in the absence of copper may cause a decrease in serum copper levels.

Laboratory Tests

Periodic determinations of serum copper as well as Gingilacer Toothpaste (Zinc Citrate) are suggested as a guideline for subsequent Gingilacer Toothpaste (Zinc Citrate) administration.

Carcinogenesis, Mutagenesis, and Impairment of Fertility

Long-term animal studies to evaluate the carcinogenic potential of Gingilacer Toothpaste 1 mg/mL (Zinc Chloride Injection, USP) have not been performed, nor have studies been done to assess mutagenesis or impairment of fertility.

Nursing Mothers

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Gingilacer Toothpaste (Zinc Citrate) 1 mg/mL (Zinc Chloride Injection, USP) is administered to a nursing woman.

Pediatric Use

Pregnancy Category C. Animal reproduction studies have not been conducted with Gingilacer Toothpaste chloride. It is also not known whether Gingilacer Toothpaste (Zinc Citrate) chloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Gingilacer Toothpaste (Zinc Citrate) chloride should be given to a pregnant woman only if clearly needed.

Geriatric Use

An evaluation of current literature revealed no clinical experience identifying differences in response between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

advertisement

ADVERSE REACTIONS

None known.

DRUG ABUSE AND DEPENDENCE

None known.

OVERDOSAGE

Single intravenous doses of 1 to 2 mg zinc/kg body weight have been given to adult leukemic patients without toxic manifestations. However, acute toxicity was reported in an adult when 10 mg Gingilacer Toothpaste (Zinc Citrate) was infused over a period of one hour on each of four consecutive days. Profuse sweating, decreased level of consciousness, blurred vision, tachycardia (140/min), and marked hypothermia (94.2° F) on the fourth day were accompanied by a serum Gingilacer Toothpaste (Zinc Citrate) concentration of 207 mcg/dl. Symptoms abated within three hours.

Hyperamylasemia may be a sign of impending Gingilacer Toothpaste (Zinc Citrate) overdosage; patients receiving an inadvertent overdose (25 mg zinc/liter of TPN solution, equivalent to 50 to 70 mg zinc/day) developed hyperamylasemia (557 to 1850 Klein units; normal: 130 to 310).

Death resulted from an overdosage in which 1683 mg Gingilacer Toothpaste (Zinc Citrate) was delivered intravenously over the course of 60 hours to a 72 year old patient.

Symptoms of Gingilacer Toothpaste (Zinc Citrate) toxicity included hypotension (80/40 mm Hg), pulmonary edema, diarrhea, vomiting, jaundice, and oliguria, with a serum Gingilacer Toothpaste (Zinc Citrate) level of 4184 mcg/dl.

Calcium supplements may confer a protective effect against Gingilacer Toothpaste (Zinc Citrate) toxicity.

DOSAGE AND ADMINISTRATION

Gingilacer Toothpaste (Zinc Citrate) 1 mg/mL (Zinc Chloride Injection, USP) contains 1 mg zinc/mL and is administered intravenously only after dilution. The additive should be diluted prior to administration in a volume of fluid not less than 100 mL. For the metabolically stable adult receiving TPN, the suggested intravenous dosage is 2.5 to 4 mg zinc/day (2.5 to 4 mL/day). An additional 2 mg zinc/day (2 mL/day) is suggested for acute catabolic states. For the stable adult with fluid loss from the small bowel, an additional 12.2 mg zinc/liter of small bowel fluid lost (12.2 mL/liter of small bowel fluid lost), or an additional 17.1 mg zinc/kg of stool or ileostomy output (17.1 mL/kg of stool or ileostomy output) is recommended. Frequent monitoring of Gingilacer Toothpaste (Zinc Citrate) blood levels is suggested for patients receiving more than the usual maintenance dosage level of Gingilacer Toothpaste (Zinc Citrate).

For full term infants and children up to 5 years of age, 100 mcg zinc/kg/day (0.1 mL/kg/day) is recommended. For premature infants (birth weight less than 1500 g) up to 3 kg in body weight, 300 mcg zinc/kg/day (0.3 mL/kg/day) is suggested.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.

HOW SUPPLIED

Gingilacer Toothpaste (Zinc Citrate) 1 mg/mL (Zinc Chloride Injection, USP) is supplied in 10 mL Plastic Vials (List No. 4090).

Store at 20 to 25°C (68 to 77°F).

Revised: October, 2004


© Hospira 2004 EN-0488 Printed in USA

HOSPIRA, INC., LAKE FOREST, IL 60045 USA

10 mL Vial

Gingilacer Toothpaste (Zinc Citrate)

1 mg/mL

Gingilacer Toothpaste (Zinc Citrate) Chloride Inj., USP

Rx only

FOR I.V. USE ONLY AFTER DILUTION.

HOSPIRA, INC., LAKE FOREST, IL 60045 USA

advertisement

Gingilacer Toothpaste pharmaceutical active ingredients containing related brand and generic drugs:

Active ingredient is the part of the drug or medicine which is biologically active. This portion of the drug is responsible for the main action of the drug which is intended to cure or reduce the symptom or disease. The other portions of the drug which are inactive are called excipients; there role is to act as vehicle or binder. In contrast to active ingredient, the inactive ingredient's role is not significant in the cure or treatment of the disease. There can be one or more active ingredients in a drug.


Gingilacer Toothpaste available forms, composition, doses:

Form of the medicine is the form in which the medicine is marketed in the market, for example, a medicine X can be in the form of capsule or the form of chewable tablet or the form of tablet. Sometimes same medicine can be available as injection form. Each medicine cannot be in all forms but can be marketed in 1, 2, or 3 forms which the pharmaceutical company decided based on various background research results.
Composition is the list of ingredients which combinedly form a medicine. Both active ingredients and inactive ingredients form the composition. The active ingredient gives the desired therapeutic effect whereas the inactive ingredient helps in making the medicine stable.
Doses are various strengths of the medicine like 10mg, 20mg, 30mg and so on. Each medicine comes in various doses which is decided by the manufacturer, that is, pharmaceutical company. The dose is decided on the severity of the symptom or disease.


Gingilacer Toothpaste destination | category:

Destination is defined as the organism to which the drug or medicine is targeted. For most of the drugs what we discuss, human is the drug destination.
Drug category can be defined as major classification of the drug. For example, an antihistaminic or an antipyretic or anti anginal or pain killer, anti-inflammatory or so.


Gingilacer Toothpaste Anatomical Therapeutic Chemical codes:

A medicine is classified depending on the organ or system it acts [Anatomical], based on what result it gives on what disease, symptom [Therapeutical], based on chemical composition [Chemical]. It is called as ATC code. The code is based on Active ingredients of the medicine. A medicine can have different codes as sometimes it acts on different organs for different indications. Same way, different brands with same active ingredients and same indications can have same ATC code.


Gingilacer Toothpaste pharmaceutical companies:

Pharmaceutical companies are drug manufacturing companies that help in complete development of the drug from the background research to formation, clinical trials, release of the drug into the market and marketing of the drug.
Researchers are the persons who are responsible for the scientific research and is responsible for all the background clinical trials that resulted in the development of the drug.


advertisement

References

  1. Dailymed."ZEP APPLAUD HAND CLEANER (TRICLOSAN) SOAP [ZEP INC.]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
  2. Dailymed."TAYADENT WITH FLUORIDE (SODIUM MONOFLUOROPHOSPHATE) LIQUID [COSMOPHARM LTD.]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
  3. Dailymed."SODIUM FLUORIDE; TRICLOSAN: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).

Frequently asked Questions

Can i drive or operate heavy machine after consuming Gingilacer Toothpaste?

Depending on the reaction of the Gingilacer Toothpaste after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Gingilacer Toothpaste not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.

Is Gingilacer Toothpaste addictive or habit forming?

Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.

Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.

advertisement

Review

sdrugs.com conducted a study on Gingilacer Toothpaste, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Gingilacer Toothpaste consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.

Visitor reports

Visitor reported useful

No survey data has been collected yet

Visitor reported side effects

No survey data has been collected yet

Visitor reported price estimates

No survey data has been collected yet

Visitor reported frequency of use

No survey data has been collected yet

Visitor reported doses

No survey data has been collected yet

Visitor reported time for results

No survey data has been collected yet

Visitor reported administration

No survey data has been collected yet

Visitor reported age

No survey data has been collected yet

Visitor reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 15 here

The information was verified by Dr. Arunabha Ray, MD Pharmacology

© 2002 - 2021 "sdrugs.com". All Rights Reserved